IP Verse

Curevac Ag patent opposition analysis

Latest patents of Curevac Ag opposed by its competitors

The following table provides an overview of the latest patents of Curevac Ag that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3283059Jan 3, 2024Method For Producing Rna Compositions7
EP4023755Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3521456Jan 4, 2023Methods And Means For Enhancing Rna Production3
EP3708668Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3283125Dec 29, 2021Lyophilization Of Rna2
EP3115064Nov 24, 2021Rna-Coded Antibody1
EP2680880Nov 10, 2021Vaccination In Newborns And Infants1
EP3297682Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2
EP3298142Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2
EP3294326Apr 21, 2021Prime-Boost Regimens Involving Administration Of At Least One Mrna Construct1

Top competitors of Curevac Ag